Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03950570
Title ORIN1001 in Patients With Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Orinove, Inc.
Indications

Her2-receptor negative breast cancer

breast cancer

triple-receptor negative breast cancer

Advanced Solid Tumor

Therapies

ORIN1001 + Paclitaxel

ORIN1001

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.